Sleep-Disordered_NP Breathing_NP ,_, Glucose_JJ Intolerance_NN ,_, and_CC Insulin_NP Resistance_NP The_DT Sleep_NP Heart_NP Health_NP Study_NP Naresh_NP M._NP Punjabi1_NP ,_, Eyal_NP Shahar2_NP ,_, Susan_NP Redline3_NP ,_, Daniel_NP J._NP Gottlieb4_NP ,_, Rachel_NP Givelber5_NP and_CC Helaine_NP E._NP Resnick6_NP for_IN the_DT Sleep_NP Heart_NP Health_NP Study_NP Investigators_NNS 1_CD Division_NN of_IN Pulmonary_NP and_CC Critical_NP Care_NP Medicine_NP ,_, School_NP of_IN Medicine_NP ,_, Johns_NP Hopkins_NP University_NP ,_, Baltimore_NP ,_, MD_NP ._SENT 2_CD Division_NN of_IN Epidemiology_NP ,_, School_NP of_IN Public_NP Health_NP ,_, University_NP of_IN Minnesota_NP ,_, Minneapolis_NP ,_, MN_NP ._SENT 3_CD Department_NP of_IN Pediatrics_NP ,_, Rainbow_NP Babies_NNS and_CC Children_NP 's_POS Hospital_NP ,_, Case_NP Western_NP Reserve_NP University_NP ,_, Cleveland_NP ,_, OH_NP ._SENT 4_CD Department_NP of_IN Medicine_NP ,_, School_NP of_IN Medicine_NP ,_, Boston_NP University_NP ,_, Boston_NP ,_, MA_NP ._SENT 5_CD Division_NN of_IN Pulmonary_NP and_CC Critical_NP Care_NP Medicine_NP ,_, School_NP of_IN Medicine_NP ,_, University_NP of_IN Pittsburgh_NP ,_, Pittsburgh_NP ,_, PA_NP ._SENT 6_CD MedStar_NP Research_NP Institute_NP ,_, Hyattsville_NP ,_, MD_NP ._SENT Received_VBN for_IN publication_NN September_NP 22_CD ,_, 2003_CD ;_: accepted_VBN for_IN publication_NN April_NP 8_CD ,_, 2004_CD ._SENT ABSTRACT_JJ TOP_NP ABSTRACT_NP INTRODUCTION_NP MATERIALS_NP AND_CC METHODS_NP RESULTS_NP DISCUSSION_NP REFERENCES_NP Clinic-based_JJ studies_NNS suggest_VBP that_IN sleep-disordered_JJ breathing_NN (_( SDB_NP )_) is_VBZ associated_VBN with_IN glucose_NN intolerance_NN and_CC insulin_NN resistance_NN ._SENT However_RB ,_, in_IN the_DT available_JJ studies_NNS ,_, researchers_NNS have_VBP not_RB rigorously_RB controlled_VBN for_IN confounding_VBG variables_NNS to_TO assess_VB the_DT independent_JJ relation_NN between_IN SDB_NP and_CC impaired_JJ glucose_NN metabolism_NN ._SENT The_DT objective_NN of_IN this_DT study_NN was_VBD to_TO determine_VB whether_IN SDB_NP was_VBD associated_VBN with_IN glucose_NN intolerance_NN and_CC insulin_NN resistance_NN among_IN community-dwelling_JJ subjects_NNS (_( n_NN =_SYM 2,656_CD )_) participating_VBG in_IN the_DT Sleep_NP Heart_NP Health_NP Study_NP (_( 1994-1999_CD )_) ._SENT SDB_NP was_VBD characterized_VBN with_IN the_DT respiratory_JJ disturbance_NN index_NN and_CC measurements_NNS of_IN oxygen_NN saturation_NN during_IN sleep_NN ._SENT Fasting_VBG and_CC 2-hour_JJ glucose_NN levels_NNS measured_VBN during_IN an_DT oral_JJ glucose_NN tolerance_NN test_NN were_VBD used_VBN to_TO assess_VB glycemic_JJ status_NN ._SENT Relative_JJ to_TO subjects_NNS with_IN a_DT respiratory_JJ disturbance_NN index_NN of_IN less_JJR than_IN 5.0_CD events/hour_NN (_( the_DT reference_NN category_NN )_) ,_, subjects_NNS with_IN mild_JJ SDB_NP (_( 5.0-14.9_CD events/hour_NN )_) and_CC moderate_JJ to_TO severe_JJ SDB_NP (_( >=_NN 15_CD events/hour_NN )_) had_VBD adjusted_VBN odds_NNS ratios_NNS of_IN 1.27_CD (_( 95_CD %_NN confidence_NN interval_NN :_: 0.98_CD ,_, 1.64_CD )_) and_CC 1.46_CD (_( 95_CD %_NN confidence_NN interval_NN :_: 1.09_CD ,_, 1.97_CD )_) ,_, respectively_RB ,_, for_IN fasting_VBG glucose_NN intolerance_NN (_( p_NN for_IN trend_NN <_SYM 0.01_CD )_) ._SENT Sleep-related_JJ hypoxemia_NNS was_VBD also_RB associated_VBN with_IN glucose_NN intolerance_NN independently_RB of_IN age_NN ,_, gender_NN ,_, body_NN mass_NN index_NN ,_, and_CC waist_NN circumference_NN ._SENT The_DT results_NNS of_IN this_DT study_NN suggest_VBP that_IN SDB_NP is_VBZ independently_RB associated_VBN with_IN glucose_NN intolerance_NN and_CC insulin_NN resistance_NN and_CC may_MD lead_VB to_TO type_VB 2_CD diabetes_NN mellitus_NN ._SENT diabetes_NN mellitus_NN ,_, type_NN II_NP ;_: glucose_NN intolerance_NN ;_: insulin_NN resistance_NN ;_: respiration_NN ;_: sleep_NN ;_: sleep_VB apnea_NN syndromes_NNS Abbreviations_NNS :_: Abbreviations_NNS :_: CI_NP ,_, confidence_NN interval_NN ;_: HOMA_NP ,_, homeostasis_NN model_NN assessment_NN ;_: RDI_NP ,_, respiratory_JJ disturbance_NN index_NN ;_: SHHS_NP ,_, Sleep_NP Heart_NP Health_NP Study_NP ._SENT INTRODUCTION_NN TOP_NP ABSTRACT_NP INTRODUCTION_NP MATERIALS_NP AND_CC METHODS_NP RESULTS_NP DISCUSSION_NP REFERENCES_NP Diabetes_NP mellitus_NN is_VBZ a_DT well-established_JJ risk_NN factor_NN for_IN cardiovascular_JJ disease_NN ._SENT Data_NNS from_IN the_DT Third_NP National_NP Health_NP and_CC Nutrition_NP Examination_NP Survey_NP indicate_VBP that_IN 5.1_CD percent_NN of_IN adults_NNS in_IN the_DT United_NP States_NPS have_VBP physician-diagnosed_JJ diabetes_NN and_CC an_DT additional_JJ 2.7_CD percent_NN meet_VBP the_DT criterion_NN for_IN diabetes_NN but_CC remain_VB undiagnosed_JJ (_( 1_CD )_) ._SENT It_PP is_VBZ also_RB estimated_VBN that_IN 6.9_CD percent_NN of_IN adults_NNS have_VBP elevated_VBN fasting_VBG glucose_NN levels_NNS and_CC 15.6_CD percent_NNS have_VBP abnormal_JJ glucose_NN tolerance_NN test_NN results_NNS (_( 1_CD )_) ._SENT Abnormal_JJ fasting_VBG and_CC 2-hour_JJ glucose_NN levels_NNS are_VBP risk_NN factors_NNS for_IN type_NN 2_CD diabetes_NN mellitus_NN (_( 2-6_CD )_) and_CC are_VBP independently_RB associated_VBN with_IN higher_JJR cardiovascular_JJ morbidity_NN (_( 7_CD ,_, 8_CD )_) and_CC mortality_NN (_( 9_CD ,_, 10_CD )_) ._SENT There_EX are_VBP emerging_VBG data_NNS suggesting_VBG that_DT insulin_NN resistance_NN ,_, a_DT state_NN in_IN which_WDT there_EX is_VBZ a_DT less-than-normal_JJ biologic_JJ response_NN to_TO insulin_NN ,_, may_MD also_RB play_VB an_DT important_JJ role_NN in_IN the_DT pathogenesis_NN of_IN hypertension_NN (_( 11-13_CD )_) and_CC cardiovascular_JJ disease_NN (_( 14-16_CD )_) ._SENT Recently_RB ,_, there_EX has_VBZ been_VBN increasing_VBG recognition_NN that_IN sleep-disordered_JJ breathing_NN ,_, a_DT condition_NN characterized_VBN by_IN reduction_NN or_CC complete_JJ cessation_NN of_IN airflow_NN during_IN sleep_NN ,_, may_MD impair_VB glucose_NN metabolism_NN (_( 17_CD )_) ._SENT Population-based_JJ studies_NNS have_VBP shown_VBN that_IN self-reported_JJ history_NN of_IN snoring_VBG ,_, a_DT common_JJ symptom_NN of_IN sleep-disordered_JJ breathing_NN ,_, is_VBZ independently_RB associated_VBN with_IN impaired_JJ glucose_NN tolerance_NN and_CC incident_NN type_NN 2_CD diabetes_NN mellitus_NN (_( 18_CD ,_, 19_CD )_) ._SENT A_DT number_NN of_IN clinic-based_JJ studies_NNS (_( 20-30_CD )_) have_VBP also_RB examined_VBN the_DT cross-sectional_JJ relation_NN between_IN sleep-disordered_JJ breathing_NN ,_, as_RB assessed_VBN by_IN overnight_JJ polysomnography_NN ,_, and_CC metabolic_JJ abnormalities_NNS ._SENT Most_JJS of_IN these_DT studies_NNS demonstrate_VBP that_IN sleep-disordered_JJ breathing_NN is_VBZ associated_VBN with_IN impaired_JJ glucose_NN tolerance_NN and_CC insulin_NN resistance_NN ._SENT Given_VBN that_DT sleep-disordered_JJ breathing_NN and_CC metabolic_JJ dysfunction_NN share_NN common_JJ etiologic_JJ risk_NN factors_NNS ,_, such_JJ as_IN central_JJ obesity_NN and_CC increasing_VBG age_NN ,_, adequate_JJ control_NN for_IN these_DT confounders_NNS is_VBZ critical_JJ in_IN establishing_VBG an_DT independent_JJ association_NN between_IN the_DT two_CD disorders_NNS ._SENT Moreover_RB ,_, the_DT role_NN of_IN sleep_NN duration_NN ,_, a_DT factor_NN shown_VBN to_TO impair_VB glucose_NN metabolism_NN (_( 31_CD )_) ,_, has_VBZ not_RB been_VBN adequately_RB addressed_VBN ._SENT Available_JJ studies_NNS on_IN the_DT relation_NN between_IN sleep-disordered_JJ breathing_NN and_CC metabolic_JJ dysfunction_NN have_VBP been_VBN based_VBN primarily_RB on_IN clinic_NN samples_NNS or_CC selective_JJ populations_NNS such_JJ as_IN overweight_JJ (_( 29_CD )_) or_CC hypertensive_JJ (_( 26_CD )_) subjects_NNS and_CC have_VBP lacked_VBN rigorous_JJ control_NN for_IN numerous_JJ confounders_NNS ._SENT Thus_RB ,_, the_DT primary_JJ objective_NN of_IN the_DT current_JJ investigation_NN was_VBD to_TO determine_VB whether_IN sleep-disordered_JJ breathing_NN ,_, as_RB assessed_VBN by_IN polysomnography_NN ,_, was_VBD related_VBN to_TO glucose_NN intolerance_NN and_CC insulin_NN resistance_NN in_IN a_DT sample_NN of_IN community-dwelling_VBG subjects_NNS ._SENT It_PP was_VBD hypothesized_VBN that_IN sleep-disordered_JJ breathing_NN would_MD be_VB associated_VBN with_IN glucose_NN intolerance_NN and_CC insulin_NN resistance_NN independently_RB of_IN the_DT confounding_VBG influences_NNS of_IN age_NN ,_, gender_NN ,_, weight_NN ,_, and_CC body_NN fat_NN distribution_NN ._SENT It_PP was_VBD also_RB hypothesized_VBN that_IN physiologic_JJ indices_NN of_IN intermittent_JJ hypoxemia_NN and_CC recurrent_JJ arousals_NNS in_IN sleep-disordered_JJ breathing_NN would_MD predict_VB the_DT degree_NN of_IN metabolic_JJ dysfunction_NN ._SENT MATERIALS_NNS AND_CC METHODS_NP TOP_NP ABSTRACT_NP INTRODUCTION_NP MATERIALS_NP AND_CC METHODS_NP RESULTS_NP DISCUSSION_NP REFERENCES_NP Study_NP sample_NN The_DT current_JJ investigation_NN was_VBD based_VBN on_IN a_DT subset_NN of_IN participants_NNS enrolled_VBN in_IN the_DT multicenter_NN Sleep_NP Heart_NP Health_NP Study_NP (_( SHHS_NP )_) ._SENT The_DT specific_JJ aims_NNS and_CC design_NN of_IN the_DT SHHS_NP have_VBP been_VBN previously_RB described_VBD (_( 32_CD )_) ._SENT Briefly_RB ,_, the_DT SHHS_NP is_VBZ a_DT cohort_NN study_NN of_IN the_DT cardiovascular_JJ consequences_NNS of_IN sleep-disordered_JJ breathing_NN ._SENT The_DT baseline_JJ cohort_NN for_IN the_DT SHHS_NP was_VBD recruited_VBN from_IN nine_CD ongoing_JJ epidemiologic_JJ studies_NNS of_IN cardiovascular_JJ and_CC respiratory_JJ disease_NN ._SENT The_DT recruited_VBN cohort_NN was_VBD further_RBR characterized_VBN for_IN the_DT presence_NN of_IN sleep-disordered_JJ breathing_NN with_IN full-montage_NN polysomnography_NN ._SENT Participants_NNS from_IN the_DT "_`` parent_NN "_'' studies_NNS were_VBD considered_VBN eligible_JJ if_IN they_PP were_VBD at_IN least_JJS 40_CD years_NNS of_IN age_NN and_CC were_VBD not_RB being_VBG treated_VBN for_IN sleep-disordered_JJ breathing_NN with_IN positive_JJ airway_NN pressure_NN ,_, oxygen_NN ,_, or_CC tracheotomy_NN ._SENT The_DT final_JJ SHHS_NP cohort_NN ,_, which_WDT consisted_VBD of_IN 6,441_CD participants_NNS ,_, underwent_VBD a_DT baseline_JJ examination_NN that_WDT included_VBD home_NN polysomnography_NN and_CC a_DT battery_NN of_IN questionnaires_NNS on_IN sleep_NN habits_NNS ._SENT Informed_JJ consent_NN was_VBD obtained_VBN from_IN all_DT participants_NNS ,_, and_CC the_DT study_NN protocol_NN was_VBD approved_VBN by_IN the_DT institutional_JJ review_NN board_NN of_IN each_DT participating_VBG institution_NN ._SENT The_DT study_NN sample_NN for_IN the_DT current_JJ analysis_NN consisted_VBN of_IN a_DT subset_NN of_IN the_DT SHHS_NP cohort_NN that_IN ,_, at_IN a_DT minimum_NN ,_, had_VBD a_DT measurement_NN of_IN fasting_VBG glucose_NN level_NN ._SENT Three_CD parent_NN studies_NNS had_VBD collected_VBN data_NNS on_IN fasting_VBG glucose_NN levels_NNS :_: the_DT Atherosclerosis_NN Risk_NN in_IN Communities_NPS Study_NP ,_, the_DT Cardiovascular_NP Health_NP Study_NP ,_, and_CC the_DT Framingham_NP Heart_NP Study_NP ._SENT Results_NNS of_IN oral_JJ glucose_NN tolerance_NN testing_NN were_VBD also_RB available_JJ from_IN the_DT Atherosclerosis_NN Risk_NN in_IN Communities_NPS and_CC Cardiovascular_NP Health_NP Study_NP cohorts_NNS ,_, whereas_IN fasting_VBG insulin_NN levels_NNS were_VBD available_JJ only_RB for_IN participants_NNS in_IN the_DT Atherosclerosis_NN Risk_NN in_IN Communities_NPS Study_NP ._SENT Because_IN metabolic_JJ function_NN was_VBD assessed_VBN in_IN accordance_NN with_IN the_DT parent_NN study_NN timeline_NN ,_, only_RB those_DT measurements_NNS that_WDT had_VBD been_VBN made_VBN within_IN a_DT year_NN of_IN the_DT SHHS_NP baseline_NN polysomnogram_NN were_VBD included_VBN in_IN the_DT current_JJ analysis_NN (_( n_NN =_SYM 2,656_CD )_) ._SENT Participants_NNS were_VBD excluded_VBN if_IN they_PP were_VBD receiving_VBG insulin_NN therapy_NN or_CC using_VBG an_DT oral_JJ hypoglycemic_JJ agent_NN ._SENT Covariate_JJ data_NNS on_IN age_NN ,_, gender_NN ,_, race_NN ,_, smoking_NN status_NN (_( current_JJ ,_, former_JJ ,_, or_CC never_RB smoker_NN )_) ,_, weight_NN ,_, height_NN ,_, waist_NN circumference_NN ,_, and_CC self-reported_JJ sleep_NN duration_NN during_IN the_DT workweek_NN were_VBD ascertained_VBN as_IN part_NN of_IN the_DT SHHS_NP baseline_NN examination_NN ._SENT Polysomnography_NP Unattended_JJ polysomnography_NN was_VBD conducted_VBN in_IN each_DT participant_NN 's_POS home_NN ._SENT It_PP consisted_VBD of_IN the_DT following_VBG continuous_JJ nocturnal_JJ recordings_NNS :_: C[3]-A[2_NN ]_SYM and_CC C[4]-A[1_NP ]_SYM electroencephalograms_NNS ,_, right_JJ and_CC left_JJ electrooculograms_NNS ,_, a_DT single_JJ bipolar_JJ electrocardiogram_NN ,_, and_CC a_DT chin_NN electromyogram_NN ._SENT Continuous_JJ nocturnal_JJ recordings_NNS were_VBD also_RB acquired_VBN for_IN the_DT following_VBG physiologic_JJ parameters_NNS :_: oxyhemoglobin_NN saturation_NN (_( by_IN pulse_NN oximetry_NN )_) ,_, chest_NN and_CC abdominal_JJ excursion_NN (_( by_IN inductance_NN plethysmography_NN )_) ,_, airflow_NN (_( by_IN an_DT oronasal_JJ thermocouple_NN )_) ,_, and_CC body_NN position_NN (_( by_IN a_DT mercury_NN gauge_NN )_) ._SENT Recordings_NNS were_VBD stored_VBN in_IN real_JJ time_NN and_CC were_VBD then_RB shipped_VBN to_TO a_DT central_JJ reading_NN center_NN for_IN review_NN and_CC scoring_VBG ._SENT Details_NNS on_IN polysomnographic_JJ equipment_NN ,_, hook-up_NN procedures_NNS ,_, failure_NN rates_NNS ,_, scoring_VBG ,_, and_CC quality_NN assurance_NN and_CC control_NN have_VBP been_VBN previously_RB published_JJ (_( 33_CD )_) ._SENT Apnea_NN was_VBD identified_VBN if_IN airflow_NN was_VBD absent_JJ or_CC nearly_RB absent_JJ for_IN at_IN least_JJS 10_CD seconds_NNS ._SENT Hypopnea_NN was_VBD identified_VBN if_IN discernible_JJ ,_, discrete_JJ reductions_NNS in_IN airflow_NN or_CC thoracoabdominal_JJ movement_NN (_( at_IN least_JJS 30_CD percent_NN below_IN baseline_JJ values_NNS )_) occurred_VBD for_IN at_IN least_JJS 10_CD seconds_NNS ._SENT The_DT respiratory_JJ disturbance_NN index_NN (_( RDI_NP )_) was_VBD defined_VBN as_IN the_DT number_NN of_IN apneas_NNS or_CC hypopneas_NNS ,_, each_DT associated_VBN with_IN a_DT 4_CD percent_NN decrease_NN in_IN oxygen_NN saturation_NN ,_, per_IN hour_NN of_IN sleep_NN ._SENT Arousals_NNS were_VBD identified_VBN as_IN abrupt_JJ shifts_NNS of_IN at_IN least_JJS 3_CD seconds_NNS '_POS duration_NN in_IN electroencephalogram_NN frequency_NN ._SENT During_IN rapid_JJ eye_NN movement_NN sleep_NN ,_, scoring_VBG of_IN arousals_NNS also_RB required_VBN concurrent_JJ increases_NNS in_IN electromyogram_NN amplitude_NN ._SENT An_DT arousal_NN index_NN was_VBD defined_VBN as_IN the_DT average_JJ number_NN of_IN arousals_NNS per_IN hour_NN of_IN sleep_NN ._SENT Metabolic_JJ assessment_NN Procedures_NNS for_IN the_DT collection_NN and_CC processing_NN of_IN blood_NN samples_NNS were_VBD independently_RB established_VBN by_IN each_DT parent_NN study_NN ._SENT After_IN an_DT overnight_JJ fast_RB of_IN at_IN least_JJS 12_CD hours_NNS ,_, venipuncture_NN was_VBD performed_VBN to_TO obtain_VB a_DT blood_NN sample_NN ._SENT In_IN the_DT Atherosclerosis_NN Risk_NN in_IN Communities_NPS and_CC Cardiovascular_NP Health_NP Study_NP cohorts_NNS ,_, a_DT 75-g_JJ dose_NN of_IN glucose_NN was_VBD then_RB given_VBN orally_RB to_TO consenting_VBG nondiabetic_JJ participants_NNS ._SENT A_DT second_JJ venipuncture_NN was_VBD performed_VBN 2_CD hours_NNS after_IN the_DT glucose_NN challenge_NN ._SENT Extracted_VBN serum_NN was_VBD stored_VBN at_IN -70°C_NN for_IN further_JJR analyses_NNS ._SENT Serum_NP glucose_NN level_NN was_VBD measured_VBN by_IN means_NNS of_IN the_DT hexokinase_NN method_NN ._SENT Serum_NP insulin_NN level_NN was_VBD measured_VBN by_IN commercial_JJ radioimmunoassay_NN ._SENT On_IN the_DT basis_NN of_IN the_DT fasting_VBG plasma_NN glucose_NN levels_NNS ,_, participants_NNS were_VBD categorized_VBN (_( 34_CD )_) as_IN having_VBG normal_JJ glucose_NN tolerance_NN (_( <110_mg/dl), =_SYM 126_CD mg/dl_NN )_) ._SENT In_IN participants_NNS with_IN data_NNS from_IN oral_JJ glucose_NN tolerance_NN testing_NN ,_, glucose_NN tolerance_NN was_VBD defined_VBN (_( 34_LS )_) as_RB follows_VBZ :_: normal_JJ glucose_NN tolerance_NN (_( <140_mg/dl), =_SYM 140_CD mg/dl_NN and_CC <200_mg/dl), =_SYM 200_CD mg/dl_NN )_) ._SENT For_IN participants_NNS with_IN data_NNS on_IN fasting_VBG insulin_NN level_NN and_CC nondiabetic_JJ fasting_VBG glucose_NN values_NNS ,_, the_DT homeostasis_NN model_NN assessment_NN (_( HOMA_NP )_) index_NN was_VBD used_VBN as_IN a_DT measure_NN of_IN insulin_NN resistance_NN (_( 35_CD )_) ._SENT The_DT HOMA_NP index_NN ,_, a_DT commonly_RB used_VBN surrogate_NN for_IN insulin_NN resistance_NN ,_, is_VBZ calculated_VBN as_IN a_DT product_NN of_IN the_DT fasting_VBG glucose_NN (_( G[0_NP ]_SYM )_) (_( mmol/liter_NN )_) and_CC fasting_VBG insulin_NN (_( I[0_NP ]_SYM )_) (_( µU/liter_NN )_) values_NNS divided_VBN by_IN the_DT constant_JJ 22.5_CD :_: HOMA_NN =_SYM (_( G[0_NP ]x_NP I[0])/22.5_NP ._SENT The_DT HOMA_NP index_NN correlates_VBZ well_RB with_IN more_JJR complex_JJ measures_NNS of_IN insulin_NN resistance_NN such_JJ as_IN the_DT frequently_RB sampled_VBN intravenous_JJ glucose_NN tolerance_NN test_NN at_IN fasting_VBG glucose_NN levels_NNS less_JJR than_IN 126_CD mg/dl_NN ._SENT Statistical_JJ analysis_NN Unadjusted_JJ differences_NNS in_IN continuous_JJ and_CC categorical_JJ variables_NNS across_IN categories_NNS of_IN predictor_NN variables_NNS were_VBD assessed_VBN for_IN significance_NN using_VBG t_NN tests_NNS or_CC {_( chi_NN }_) 2_CD tests_NNS ,_, as_RB appropriate_JJ ._SENT The_DT primary_JJ outcome_NN variables_NNS included_VBD fasting_VBG glucose_NN level_NN ,_, 2-hour_JJ glucose_NN level_NN ,_, and_CC HOMA_NP index_NN ._SENT Because_IN fasting_VBG and_CC 2-hour_JJ glucose_NN levels_NNS were_VBD grouped_VBN into_IN normal_JJ ,_, impaired_JJ ,_, and_CC diabetic_JJ categories_NNS ,_, ordinal_JJ logistic_JJ regression_NN was_VBD used_VBN to_TO model_VB the_DT associations_NNS between_IN indices_NN of_IN sleep-disordered_JJ breathing_NN and_CC impaired_JJ glucose_NN metabolism_NN ._SENT The_DT ordinal_JJ model_NN specifies_VBZ a_DT log-linear_JJ relation_NN for_IN the_DT odds_NNS of_IN being_VBG in_IN one_CD category_NN (_( e.g._FW ,_, impaired_JJ glucose_NN tolerance_NN )_) as_IN compared_VBN with_IN being_VBG in_IN a_DT lower_JJR category_NN (_( e.g._FW ,_, normal_JJ glucose_NN tolerance_NN )_) and_CC assumes_VBZ proportional_JJ odds_NNS for_IN any_DT dichotomy_NN of_IN the_DT three_CD levels_NNS of_IN glucose_NN tolerance_NN status_NN ._SENT The_DT assumption_NN of_IN proportional_JJ odds_NNS was_VBD tested_VBN and_CC found_VBN to_TO be_VB valid_JJ for_IN the_DT described_VBN models_NNS ._SENT The_DT primary_JJ independent_JJ variables_NNS included_VBD the_DT RDI_NP ,_, the_DT arousal_NN index_NN ,_, and_CC two_CD different_JJ indices_NN of_IN nocturnal_JJ hypoxemia_NNS (_( percentage_NN of_IN sleep_NN time_NN with_IN oxyhemoglobin_NN saturation_NN below_IN 90_CD percent_NN and_CC average_JJ oxyhemoglobin_NN saturation_NN during_IN sleep_NN )_) ._SENT To_TO examine_VB the_DT associations_NNS between_IN physiologic_JJ indices_NN of_IN sleep-disordered_JJ breathing_NN and_CC glucose_NN metabolism_NN ,_, we_PP developed_VBD separate_JJ multivariable_JJ models_NNS for_IN each_DT variable_NN of_IN disease_NN severity_NN ._SENT For_IN the_DT RDI_NP ,_, the_DT following_NN commonly_RB used_VBD cutpoints_NNS were_VBD employed_VBN to_TO define_VB categories_NNS of_IN disease_NN severity_NN :_: <5.0_events/hour =_SYM 15_CD events/hour_NN (_( moderate_JJ to_TO severe_JJ sleep-disordered_JJ breathing_NN )_) ._SENT These_DT thresholds_NNS have_VBP been_VBN applied_VBN previously_RB in_IN a_DT number_NN of_IN studies_NNS on_IN sleep-disordered_JJ breathing_NN and_CC are_VBP of_IN clinical_JJ value_NN ._SENT For_IN other_JJ physiologic_JJ indices_NN of_IN the_DT severity_NN of_IN sleep-disordered_JJ breathing_NN ,_, the_DT study_NN sample_NN was_VBD grouped_VBN into_IN quartiles_NNS of_IN the_DT predictor_NN variable_NN ,_, with_IN the_DT lowest_JJS quartile_NN serving_VBG as_IN the_DT reference_NN category_NN ,_, using_VBG distributions_NNS based_VBN on_IN subjects_NNS with_IN fasting_VBG glucose_NN data_NNS ._SENT We_PP quantified_VBD the_DT relation_NN between_IN each_DT predictor_NN and_CC outcome_NN by_IN computing_VBG the_DT odds_NNS ratio_NN for_IN glucose_NN intolerance_NN in_IN a_DT comparison_NN of_IN the_DT reference_NN category_NN with_IN other_JJ categories_NNS of_IN the_DT primary_JJ predictor_NN ._SENT To_TO adjust_VB for_IN potential_JJ confounders_NNS ,_, we_PP entered_VBD covariates_NNS into_IN the_DT ordinal_JJ model_NN that_WDT included_VBD the_DT primary_JJ predictor_NN ._SENT The_DT following_VBG covariates_NNS were_VBD included_VBN in_IN all_DT multivariable_JJ models_NNS :_: age_NN ,_, gender_NN ,_, ethnicity_NN ,_, smoking_NN status_NN ,_, body_NN mass_NN index_NN (_( weight_NN (kg)/height_NN (m)2)_NN ,_, waist_NN circumference_NN ,_, and_CC self-reported_JJ sleep_NN duration_NN (_( =_SYM <_5, =_SYM 9_CD hours_NNS )_) ._SENT We_PP examined_VBD the_DT effects_NNS of_IN a_DT multicenter_NN design_NN by_IN adding_VBG a_DT term_NN for_IN each_DT center_NN in_IN the_DT regression_NN models_NNS ._SENT We_PP tested_VBD for_IN a_DT linear_JJ trend_NN in_IN the_DT odds_NNS ratios_NNS for_IN the_DT primary_JJ predictor_NN by_IN comparing_VBG the_DT log-likelihoods_NNS from_IN distinct_JJ models_NNS that_WDT included_VBD the_DT predictor_NN variable_NN as_IN an_DT ordinal_NN and_CC a_DT nominal_JJ variable_NN ._SENT Associations_NNS between_IN the_DT HOMA_NP index_NN and_CC measures_NNS of_IN sleep-disordered_JJ breathing_NN were_VBD examined_VBN using_VBG multivariable_JJ linear_JJ regression_NN analyses_NNS that_WDT included_VBD adjustments_NNS for_IN the_DT aforementioned_JJ confounders_NNS ._SENT Because_IN measurements_NNS of_IN metabolic_JJ function_NN were_VBD derived_VBN from_IN parent_NN studies_NNS and_CC were_VBD not_RB part_NN of_IN the_DT baseline_JJ SHHS_NP examination_NN ,_, a_DT number_NN of_IN sensitivity_NN analyses_NNS were_VBD conducted_VBN ._SENT First_RB ,_, analyses_NNS were_VBD stratified_VBN by_IN parent_NN cohort_NN ._SENT These_DT showed_VBD that_IN the_DT inferences_NNS were_VBD relatively_RB consistent_JJ across_IN the_DT parent_NN cohorts_NNS ._SENT Thus_RB ,_, information_NN from_IN the_DT parent_NN cohorts_NNS is_VBZ collectively_RB presented_VBN for_IN parsimony_NN ._SENT Second_JJ ,_, different_JJ time_NN windows_NNS around_IN the_DT polysomnogram_NN (_( 3-12_CD months_NNS )_) were_VBD also_RB used_VBN ._SENT These_DT analyses_NNS showed_VBD that_IN as_IN the_DT time_NN window_NN was_VBD decreased_VBN from_IN 12_CD months_NNS to_TO 3_CD months_NNS ,_, the_DT strength_NN of_IN the_DT associations_NNS increased_VBD ._SENT A_DT 12-month_JJ window_NN was_VBD used_VBN for_IN the_DT final_JJ analyses_NNS ,_, since_IN indices_NN of_IN sleep-disordered_JJ breathing_NN are_VBP not_RB likely_JJ to_TO change_VB over_IN a_DT year_NN (_( 36_CD ,_, 37_CD )_) ._SENT Third_JJ ,_, the_DT potential_JJ impact_NN of_IN excluding_VBG diabetic_JJ subjects_NNS who_WP were_VBD taking_VBG an_DT oral_JJ hypoglycemic_JJ agent_NN or_CC receiving_VBG insuling_NN therapy_NN (_( n_NN =_SYM 223_CD )_) was_VBD assessed_VBN ._SENT Analyses_NNS that_WDT included_VBD participants_NNS on_IN diabetic_JJ medication_NN in_IN the_DT "_`` diabetic_JJ "_'' category_NN showed_VBD that_IN the_DT associations_NNS of_IN interest_NN were_VBD similar_JJ or_CC slightly_RB stronger_JJR ._SENT Finally_RB ,_, given_VBN the_DT small_JJ number_NN of_IN non-Caucasians_NNS in_IN the_DT study_NN sample_NN ,_, we_PP developed_VBD statistical_JJ models_NNS with_IN and_CC without_IN this_DT subset_NN ._SENT Given_VBN that_IN the_DT inferences_NNS were_VBD not_RB different_JJ ,_, results_NNS for_IN the_DT aggregate_JJ sample_NN are_VBP presented_VBN ._SENT All_DT statistical_JJ analyses_NNS were_VBD performed_VBN using_VBG SAS_NP statistical_JJ software_NN ,_, version_NN 9.0_CD (_( SAS_NP Institute_NP ,_, Inc._NP ,_, Cary_NP ,_, North_NP Carolina_NP )_) ._SENT RESULTS_VBZ TOP_NP ABSTRACT_NP INTRODUCTION_NP MATERIALS_NP AND_CC METHODS_NP RESULTS_NP DISCUSSION_NP REFERENCES_NP Sample_NP characteristics_NNS A_DT total_NN of_IN 2,656_CD participants_NNS met_VBD the_DT enrollment_NN criteria_NNS and_CC had_VBD data_NNS on_IN fasting_VBG glucose_NN levels_NNS that_WDT were_VBD obtained_VBN within_IN a_DT 12-month_JJ period_NN around_IN the_DT overnight_JJ polysomnogram_NN ._SENT The_DT distribution_NN of_IN participants_NNS within_IN the_DT three_CD RDI_NP categories_NNS was_VBD as_RB follows_VBZ :_: 52.3_CD percent_NN (_( <5_events/hour), =_SYM 15_CD events/hour_NN )_) ._SENT Numbers_NNS of_IN participants_NNS from_IN the_DT three_CD parent_NN cohorts_NNS were_VBD as_RB follows_VBZ :_: 1,144_CD from_IN the_DT Atherosclerosis_NN Risk_NN in_IN Communities_NPS Study_NP ,_, 981_CD from_IN the_DT Cardiovascular_NP Health_NP Study_NP ,_, and_CC 531_CD from_IN the_DT Framingham_NP Heart_NP Study_NP ._SENT Of_IN the_DT 2,656_CD participants_NNS with_IN fasting_VBG glucose_NN levels_NNS measured_VBN within_IN a_DT year_NN of_IN the_DT polysomnogram_NN ,_, 1,930_CD had_VBD 2-hour_JJ glucose_NN data_NNS from_IN the_DT oral_JJ glucose_NN tolerance_NN test_NN and_CC 1,144_CD had_VBD data_NNS on_IN fasting_VBG insulin_NN level_NN ._SENT Table_NN 1_CD summarizes_VBZ data_NNS on_IN the_DT demographic_JJ variables_NNS for_IN the_DT participants_NNS included_VBD in_IN the_DT current_JJ analyses_NNS ._SENT View_VB this_DT table_NN :_: TABLE_NN 1_CD ._SENT Demographic_JJ characteristics_NNS of_IN the_DT study_NN sample_NN ,_, Sleep_NP Heart_NP Health_NP Study_NP ,_, 1994-1999_CD Sleep-disordered_JJ breathing_NN and_CC glucose_NN intolerance_NN To_TO assess_VB whether_IN indices_NN of_IN severity_NN of_IN sleep-disordered_JJ breathing_NN were_VBD associated_VBN with_IN glucose_NN intolerance_NN ,_, we_PP initially_RB examined_VBD the_DT frequency_NN of_IN impaired_JJ or_CC diabetic_JJ glucose_NN values_NNS as_IN a_DT function_NN of_IN the_DT RDI_NP ._SENT An_DT increase_NN in_IN the_DT RDI_NP was_VBD associated_VBN with_IN an_DT increase_NN in_IN the_DT prevalence_NN of_IN impaired_JJ and_CC diabetic_JJ fasting_VBG glucose_NN levels_NNS from_IN 8.7_CD percent_NN and_CC 4.0_CD percent_NN ,_, respectively_RB ,_, in_IN subjects_NNS with_IN an_DT RDI_NP of_IN <5_events/hour =_SYM 15_CD events/hour_NN ._SENT Similarly_RB ,_, the_DT prevalence_NN of_IN impaired_JJ and_CC diabetic_JJ 2-hour_JJ glucose_NN values_NNS increased_VBN from_IN 29.1_CD percent_NN and_CC 9.3_CD percent_NN ,_, respectively_RB ,_, in_IN subjects_NNS with_IN an_DT RDI_NP of_IN <5_events/hour =_SYM 15_CD events/hour_NN ._SENT In_IN comparison_NN with_IN an_DT RDI_NP of_IN <5_JJ events/hour_NN (_( no_DT sleep-disordered_JJ breathing_NN )_) ,_, the_DT unadjusted_JJ odds_NNS ratios_NNS for_IN glucose_NN intolerance_NN based_VBN on_IN the_DT fasting_VBG glucose_NN values_NNS for_IN subjects_NNS with_IN mild_JJ sleep-disordered_JJ breathing_NN (_( RDI_NP of_IN 5.0-14.9_CD events/hour_NN )_) and_CC moderate_JJ to_TO severe_JJ sleep-disordered_JJ breathing_NN (_( RDI_NP of_IN >=_NP 15_CD events/hour_NN )_) were_VBD 1.67_CD (_( 95_CD percent_NN confidence_NN interval_NN (_( CI_NP )_) :_: 1.32_CD ,_, 2.11_CD )_) and_CC 2.44_CD (_( 95_CD percent_NN CI_NP :_: 1.89_CD ,_, 3.16_CD )_) ,_, respectively_RB (_( p_NN <_SYM 0.0001_CD for_IN linear_JJ trend_NN )_) ._SENT Similarly_RB ,_, the_DT unadjusted_JJ odds_NNS ratios_NNS for_IN glucose_NN intolerance_NN based_VBN on_IN the_DT 2-hour_JJ glucose_NN levels_NNS for_IN subjects_NNS with_IN mild_JJ and_CC moderate_JJ to_TO severe_JJ sleep-disordered_JJ breathing_NN were_VBD 1.26_CD (_( 95_CD percent_NN CI_NP :_: 1.03_CD ,_, 1.54_CD )_) and_CC 1.68_CD (_( 95_CD percent_NN CI_NP :_: 1.33_CD ,_, 2.13_CD )_) ,_, respectively_RB (_( p_NN <_SYM 0.0001_CD for_IN linear_JJ trend_NN )_) ._SENT To_TO determine_VB whether_IN sleep-disordered_JJ breathing_NN was_VBD independently_RB associated_VBN with_IN glucose_NN intolerance_NN ,_, we_PP used_VBD multivariable_JJ ordinal_JJ logistic_JJ models_NNS to_TO examine_VB the_DT associations_NNS between_IN the_DT RDI_NP and_CC glucose_NN tolerance_NN ._SENT Although_IN there_EX was_VBD attenuation_NN in_IN the_DT strength_NN of_IN the_DT associations_NNS with_IN multivariable_JJ adjustment_NN ,_, we_PP noted_VBD a_DT positive_JJ and_CC significant_JJ linear_JJ trend_NN in_IN the_DT odds_NNS of_IN glucose_NN intolerance_NN with_IN increasing_VBG RDI_NP after_IN adjusting_VBG for_IN age_NN ,_, gender_NN ,_, race_NN ,_, body_NN mass_NN index_NN ,_, waist_NN circumference_NN ,_, smoking_NN history_NN ,_, and_CC self-reported_JJ sleep_NN duration_NN (_( table_NN 2_CD )_) ._SENT Inclusion_NN of_IN subjects_NNS with_IN diagnosed_VBN diabetes_NN mellitus_NN who_WP were_VBD taking_VBG medication_NN slightly_RB increased_VBD the_DT magnitude_NN of_IN the_DT association_NN between_IN RDI_NP and_CC metabolic_JJ dysfunction_NN (_( data_NNS not_RB shown_VBN )_) ._SENT View_VB this_DT table_NN :_: TABLE_NN 2_CD ._SENT Adjusted_JJ odds_NNS ratios_NNS for_IN glucose_NN intolerance_NN based_VBN on_IN fasting_VBG and_CC 2-hour_JJ glucose_NN levels_NNS ,_, Sleep_NP Heart_NP Health_NP Study_NP ,_, 1994-1999*_NP ,_, {_( dagger_NN }_) We_PP further_RBR investigated_VBD the_DT association_NN between_IN sleep-disordered_JJ breathing_NN and_CC metabolic_JJ dysfunction_NN by_IN modeling_VBG the_DT relations_NNS between_IN degree_NN of_IN nocturnal_JJ hypoxemia_NN ,_, arousal_NN frequency_NN ,_, and_CC glucose_NN intolerance_NN ._SENT Average_JJ oxyhemoglobin_NN saturation_NN during_IN sleep_NN and_CC percentage_NN of_IN sleep_NN time_NN below_IN an_DT oxyhemoglobin_NN saturation_NN level_NN of_IN 90_CD percent_NN were_VBD used_VBN as_IN separate_JJ indices_NN of_IN sleep-related_JJ hypoxemia_NN ._SENT As_IN table_NN 2_CD shows_NNS ,_, increasing_VBG hypoxemia_NN during_IN sleep_NN was_VBD independently_RB associated_VBN with_IN glucose_NN intolerance_NN ,_, on_IN the_DT basis_NN of_IN either_DT fasting_VBG glucose_NN values_NNS or_CC 2-hour_JJ glucose_NN values_NNS ._SENT Average_JJ oxyhemoglobin_NN saturation_NN during_IN sleep_NN and_CC percentage_NN of_IN sleep_NN time_NN below_IN an_DT oxyhemoglobin_NN saturation_NN level_NN of_IN 90_CD percent_NN were_VBD associated_VBN with_IN fasting_VBG glucose_NN intolerance_NN ._SENT Similar_JJ but_CC somewhat_RB modest_JJ associations_NNS were_VBD also_RB noted_VBN between_IN the_DT 2-hour_JJ measure_NN of_IN glucose_NN tolerance_NN and_CC average_JJ oxyhemoglobin_NN saturation_NN during_IN sleep_NN and_CC percentage_NN of_IN sleep_NN time_NN below_IN an_DT oxyhemoglobin_NN saturation_NN level_NN of_IN 90_CD percent_NN ._SENT In_IN contrast_NN ,_, no_DT significant_JJ associations_NNS between_IN arousal_NN frequency_NN and_CC glucose_NN tolerance_NN were_VBD noted_VBN with_IN either_CC the_DT fasting_VBG values_NNS or_CC the_DT 2-hour_JJ values_NNS (_( table_NN 2_CD )_) ._SENT Sleep-disordered_JJ breathing_NN and_CC insulin_NN resistance_NN We_PP investigated_VBD the_DT association_NN between_IN severity_NN of_IN sleep-disordered_JJ breathing_NN and_CC insulin_NN resistance_NN by_IN modeling_VBG the_DT relation_NN between_IN the_DT RDI_NP and_CC the_DT HOMA_NP index_NN ._SENT Figure_NN 1_CD shows_NNS the_DT adjusted_VBN values_NNS for_IN the_DT HOMA_NP index_NN as_IN a_DT function_NN of_IN the_DT RDI_NP ._SENT Participants_NNS with_IN moderate_JJ to_TO severe_JJ sleep-disordered_JJ breathing_NN (_( RDI_NP of_IN >=_NP 15_CD events/hour_NN )_) were_VBD noted_VBN to_TO have_VB higher_JJR values_NNS for_IN the_DT HOMA_NP index_NN ,_, indicating_VBG an_DT insulin-resistant_JJ state_NN ,_, independently_RB of_IN age_NN ,_, gender_NN ,_, ethnicity_NN ,_, smoking_NN status_NN ,_, body_NN mass_NN index_NN ,_, waist_NN circumference_NN ,_, and_CC sleep_NN duration_NN ._SENT As_IN the_DT time_NN window_NN between_IN the_DT metabolic_JJ assessment_NN and_CC the_DT sleep_NN study_NN was_VBD decreased_VBN from_IN 12_CD months_NNS to_TO 3_CD months_NNS ,_, a_DT stronger_JJR association_NN between_IN the_DT two_CD variables_NNS was_VBD observed_VBN (_( figure_NN 1_CD )_) ._SENT View_NN larger_JJR version_NN (_( 24K_NP )_) :_: FIGURE_NN 1_CD ._SENT Adjusted_VBN mean_JJ value_NN of_IN the_DT homeostasis_NN model_NN assessment_NN (_( HOMA_NP )_) index_NN as_IN a_DT function_NN of_IN the_DT respiratory_JJ disturbance_NN index_NN (_( RDI_NP )_) for_IN 12-month_JJ (_( n_NN =_SYM 1,067_CD )_) and_CC 3-month_JJ (_( n_NN =_SYM 405_CD )_) time_NN windows_NNS ,_, Sleep_NP Heart_NP Health_NP Study_NP ,_, 1994-1999_CD ._SENT Data_NNS were_VBD adjusted_VBN for_IN age_NN ,_, gender_NN ,_, smoking_NN status_NN ,_, body_NN mass_NN index_NN ,_, waist_NN circumference_NN ,_, and_CC self-reported_JJ sleep_NN duration_NN ._SENT Bars_NNS ,_, standard_JJ error_NN ._SENT To_TO investigate_VB the_DT differential_JJ impact_NN of_IN sleep-related_JJ hypoxemia_NNS and_CC arousals_NNS on_IN insulin_NN resistance_NN ,_, we_PP examined_VBD indices_NN of_IN nocturnal_JJ hypoxemia_NN and_CC arousal_NN frequency_NN as_IN predictors_NNS of_IN the_DT HOMA_NP index_NN ._SENT Both_DT average_JJ oxyhemoglobin_NN saturation_NN during_IN sleep_NN and_CC percentage_NN of_IN sleep_NN time_NN below_IN a_DT saturation_NN level_NN of_IN 90_CD percent_NN were_VBD independently_RB associated_VBN with_IN the_DT HOMA_NP index_NN ._SENT Figure_NN 2_CD shows_VBZ adjusted_JJ levels_NNS of_IN the_DT HOMA_NP index_NN as_IN a_DT function_NN of_IN the_DT two_CD indices_NN of_IN sleep-related_JJ hypoxemia_NN ._SENT In_IN addition_NN to_TO the_DT relation_NN between_IN the_DT HOMA_NP index_NN and_CC hypoxemia_NN during_IN sleep_NN ,_, we_PP also_RB noted_VBD a_DT modest_JJ and_CC statistically_RB significant_JJ association_NN between_IN the_DT HOMA_NP index_NN and_CC the_DT arousal_NN frequency_NN ._SENT Participants_NNS in_IN the_DT highest_JJS quartile_NN of_IN arousal_NN frequency_NN (_( >=_NN 24.18_CD events/hour_NN )_) had_VBD a_DT mean_NN adjusted_VBN HOMA_NP level_NN of_IN 2.84_CD (_( standard_NN error_NN ,_, 0.13_CD )_) ,_, whereas_IN subjects_NNS in_IN the_DT lowest_JJS quartile_NN (_( <12.36_JJ events/hour_NN )_) had_VBD a_DT mean_NN adjusted_VBN HOMA_NP level_NN of_IN 2.51_CD (_( standard_NN error_NN ,_, 0.13_CD )_) (_( p_NN =_SYM 0.02_CD )_) ._SENT View_NN larger_JJR version_NN (_( 20K_NP )_) :_: FIGURE_NN 2_CD ._SENT Adjusted_VBN mean_JJ value_NN of_IN the_DT homeostasis_NN model_NN assessment_NN (_( HOMA_NP )_) index_NN according_VBG to_TO two_CD different_JJ indices_NN of_IN sleep-related_JJ hypoxemia_NNS (_( 12-month_JJ time_NN window_NN ;_: n_NN =_SYM 1,067_CD )_) ,_, Sleep_NP Heart_NP Health_NP Study_NP ,_, 1994-1999_CD ._SENT Data_NNS were_VBD adjusted_VBN for_IN age_NN ,_, gender_NN ,_, smoking_NN status_NN ,_, body_NN mass_NN index_NN ,_, waist_NN circumference_NN ,_, and_CC self-reported_JJ sleep_NN duration_NN ._SENT *p_NN =_SYM 0.04_CD and_CC **p_NNS =_SYM 0.01_CD for_IN comparisons_NNS with_IN the_DT first_JJ quartile_NN ._SENT Bars_NNS ,_, standard_JJ error_NN ._SENT DISCUSSION_NN TOP_NP ABSTRACT_NP INTRODUCTION_NP MATERIALS_NP AND_CC METHODS_NP RESULTS_NP DISCUSSION_NP REFERENCES_NP The_DT results_NNS of_IN this_DT cross-sectional_JJ study_NN in_IN a_DT large_JJ sample_NN of_IN community-dwelling_NN subjects_NNS demonstrate_VBP that_IN sleep-disordered_JJ breathing_NN is_VBZ independently_RB associated_VBN with_IN glucose_NN intolerance_NN and_CC insulin_NN resistance_NN ._SENT Using_VBG full-night_JJ polysomnography_NN to_TO characterize_VB breathing_VBG abnormalities_NNS during_IN sleep_NN ,_, we_PP have_VBP demonstrated_VBN that_IN sleep-disordered_JJ breathing_NN is_VBZ associated_VBN with_IN higher_JJR odds_NNS of_IN metabolic_JJ dysfunction_NN after_IN adjustment_NN for_IN several_JJ confounding_VBG covariates_NNS ,_, including_VBG age_NN ,_, gender_NN ,_, smoking_NN status_NN ,_, body_NN mass_NN index_NN ,_, waist_NN circumference_NN ,_, and_CC self-reported_JJ sleep_NN duration_NN ._SENT The_DT severity_NN of_IN sleep-disordered_JJ breathing_NN ,_, as_RB assessed_VBN by_IN the_DT RDI_NP ,_, was_VBD also_RB found_VBN to_TO be_VB independently_RB associated_VBN with_IN degree_NN of_IN insulin_NN resistance_NN ._SENT Further_JJR analyses_NNS of_IN physiologic_JJ indices_NN related_VBN to_TO sleep-disordered_JJ breathing_NN showed_VBD that_IN the_DT degree_NN of_IN sleep-related_JJ hypoxemia_NNS was_VBD strongly_RB associated_VBN with_IN indices_NN of_IN glucose_NN tolerance_NN and_CC insulin_NN resistance_NN ,_, whereas_IN disruption_NN of_IN nocturnal_JJ sleep_NN continuity_NN ,_, as_RB assessed_VBN by_IN the_DT frequency_NN of_IN arousals_NNS ,_, was_VBD found_VBN to_TO be_VB associated_VBN only_RB with_IN insulin_NN resistance_NN ,_, not_RB glucose_NN tolerance_NN ._SENT The_DT results_NNS of_IN this_DT study_NN are_VBP consistent_JJ with_IN several_JJ other_JJ clinic-based_JJ studies_NNS on_IN the_DT association_NN between_IN sleep-disordered_JJ breathing_NN ,_, glucose_NN tolerance_NN ,_, and_CC insulin_NN resistance_NN ._SENT Earlier_JJR studies_NNS that_WDT used_VBD self-reported_JJ symptoms_NNS ,_, such_JJ as_IN snoring_VBG and_CC witnessed_VBN apneas_NNS ,_, as_IN markers_NNS for_IN sleep-disordered_JJ breathing_NN showed_VBD that_IN habitual_JJ snoring_VBG was_VBD independently_RB associated_VBN with_IN glucose_NN intolerance_NN and_CC elevated_JJ fasting_VBG insulin_NN levels_NNS (_( 18_CD ,_, 19_CD )_) ._SENT Cross-sectional_JJ clinic-based_JJ studies_NNS (_( 20-30_CD )_) that_WDT have_VBP used_VBN polysomnography_NN to_TO quantify_VB the_DT severity_NN of_IN sleep-disordered_JJ breathing_NN have_VBP also_RB supported_VBN the_DT finding_NN that_IN sleep-disordered_JJ breathing_NN is_VBZ independently_RB associated_VBN with_IN altered_JJ metabolic_JJ function_NN ._SENT However_RB ,_, the_DT generalizability_NN of_IN these_DT studies_NNS has_VBZ been_VBN in_IN question_NN because_IN of_IN a_DT number_NN of_IN methodological_JJ limitations_NNS ,_, including_VBG the_DT use_NN of_IN clinical_JJ populations_NNS ,_, limited_JJ sample_NN sizes_NNS ,_, lack_NN of_IN objective_JJ data_NNS on_IN sleep_NN parameters_NNS ,_, and_CC inadequate_JJ control_NN for_IN the_DT confounding_VBG effects_NNS of_IN obesity_NN ._SENT The_DT present_JJ study_NN overcomes_VBZ many_JJ of_IN these_DT methodological_JJ limitations_NNS and_CC provides_VBZ strong_JJ support_NN for_IN an_DT independent_JJ cross-sectional_JJ association_NN between_IN sleep-disordered_JJ breathing_NN and_CC altered_JJ glucose_NN metabolism_NN ._SENT The_DT unique_JJ aspects_NNS of_IN this_DT study_NN include_VBP the_DT use_NN of_IN a_DT community-based_JJ sample_NN ,_, a_DT large_JJ sample_NN size_NN ,_, polysomnographic_JJ assessment_NN of_IN breathing_VBG during_IN sleep_NN ,_, objective_JJ measures_NNS of_IN metabolic_JJ function_NN ,_, and_CC the_DT inclusion_NN of_IN numerous_JJ confounding_VBG covariates_NNS ._SENT Although_IN this_DT study_NN adds_VBZ to_TO the_DT evidence_NN for_IN an_DT independent_JJ association_NN between_IN sleep-disordered_JJ breathing_NN and_CC metabolic_JJ dysfunction_NN ,_, currently_RB there_EX are_VBP no_DT prospective_JJ data_NNS on_IN whether_IN this_DT association_NN is_VBZ causal_JJ or_CC whether_IN intermittent_JJ hypoxemia_NN and/or_CC recurrent_JJ arousals_NNS are_VBP in_IN the_DT putative_JJ causal_JJ pathway_NN ._SENT The_DT data_NNS presented_VBD here_RB indicate_VB that_DT indices_NN of_IN sleep-related_JJ hypoxemia_NNS are_VBP related_VBN to_TO metabolic_JJ dysfunction_NN ._SENT Support_NN for_IN the_DT hypothesis_NN that_IN hypoxia_NN may_MD be_VB an_DT etiologic_JJ factor_NN comes_VBZ from_IN experimental_JJ data_NNS in_IN humans_NNS which_WDT show_VBP that_DT exposure_NN to_TO high_JJ altitude_NN (_( 38_CD )_) or_CC hypobaric_JJ hypoxia_NN (_( 39_CD )_) is_VBZ acutely_RB associated_VBN with_IN a_DT >50_JJ percent_NN decrease_NN in_IN insulin_NN sensitivity_NN ._SENT The_DT importance_NN of_IN hypoxia_NN in_IN the_DT pathogenesis_NN of_IN metabolic_JJ dysfunction_NN is_VBZ further_RBR evident_JJ in_IN animal_JJ studies_NNS (_( 40-42_CD )_) that_WDT illustrate_VBP an_DT increase_NN in_IN insulin_NN levels_NNS with_IN exposure_NN to_TO hypoxic_JJ conditions_NNS ._SENT Taken_VBN together_RB ,_, currently_RB available_JJ data_NNS suggest_VBP that_IN hypoxia_NN has_VBZ a_DT significant_JJ role_NN in_IN the_DT development_NN of_IN metabolic_JJ dysfunction_NN ._SENT Cyclical_JJ hypoxia_NN could_MD lead_VB to_TO glucose_NN intolerance_NN and_CC insulin_NN resistance_NN by_IN promoting_VBG the_DT release_NN of_IN proinflammatory_JJ cytokines_NNS ,_, such_JJ as_IN interleukin-6_NN and_CC tumor_NN necrosis_NN factor-_NN {_( alpha_NN }_) ._SENT In_IN fact_NN ,_, two_CD clinic-based_JJ studies_NNS (_( 25_CD ,_, 43_CD )_) have_VBP shown_VBN that_IN plasma_NN levels_NNS of_IN interleukin-6_NN and_CC tumor_NN necrosis_NN factor-_NN {_( alpha_NN }_) are_VBP higher_JJR in_IN patients_NNS with_IN sleep-disordered_JJ breathing_NN than_IN in_IN control_NN subjects_NNS ._SENT Interleukin-6_NP is_VBZ correlated_VBN with_IN indices_NN of_IN insulin_NN resistance_NN ,_, and_CC higher_JJR levels_NNS are_VBP associated_VBN with_IN an_DT increased_VBN risk_NN of_IN type_NN 2_CD diabetes_NN mellitus_NN (_( 44-46_CD )_) ._SENT Recent_JJ data_NNS also_RB indicate_VBP that_IN tumor_NN necrosis_NN factor-_NN {_( alpha_NN }_) has_VBZ a_DT potential_JJ role_NN in_IN the_DT development_NN of_IN insulin_NN resistance_NN (_( 47-50_CD )_) ._SENT Although_IN the_DT mechanisms_NNS through_IN which_WDT these_DT cytokines_NNS potentiate_VBP metabolic_JJ dysfunction_NN need_VBP further_JJR clarification_NN ,_, there_EX is_VBZ increasing_VBG acceptance_NN that_IN glucose_NN intolerance_NN and_CC insulin_NN resistance_NN may_MD be_VB mediated_VBN ,_, in_IN part_NN ,_, by_IN an_DT inflammatory_JJ response_NN ._SENT In_IN contrast_NN to_TO the_DT effects_NNS of_IN hypoxia_NN ,_, there_EX are_VBP no_DT data_NNS on_IN the_DT effects_NNS of_IN recurrent_JJ arousals_NNS from_IN sleep_NN on_IN metabolic_JJ function_NN ._SENT Experimentally_RB induced_VBN partial_JJ sleep_NN deprivation_NN in_IN normal_JJ ,_, healthy_JJ men_NNS has_VBZ been_VBN shown_VBN to_TO induce_VB glucose_NN intolerance_NN (_( 31_CD )_) ._SENT Recent_JJ data_NNS from_IN the_DT Nurses_NP '_POS Health_NP Study_NP (_( 51_CD )_) provide_VBP further_JJR support_NN for_IN the_DT hypothesis_NN that_IN sleep_NN loss_NN may_MD lead_VB to_TO type_VB 2_CD diabetes_NN mellitus_NN ._SENT Whether_IN the_DT secondary_JJ sleep_NN loss_NN that_WDT occurs_VBZ in_IN sleep-disordered_JJ breathing_NN because_IN of_IN recurrent_JJ arousals_NNS has_VBZ a_DT similar_JJ effect_NN on_IN metabolic_JJ function_NN is_VBZ not_RB known_VBN ._SENT The_DT results_NNS of_IN the_DT current_JJ study_NN would_MD suggest_VB that_DT sleep_NN fragmentation_NN ,_, as_RB indicated_VBN by_IN recurrent_JJ cortical_JJ arousals_NNS measured_VBN by_IN standard_JJ criteria_NNS ,_, is_VBZ associated_VBN with_IN indices_NN of_IN insulin_NN resistance_NN and_CC might_MD also_RB be_VB important_JJ in_IN the_DT causal_JJ pathway_NN to_TO metabolic_JJ dysfunction_NN ._SENT These_DT data_NNS should_MD be_VB interpreted_VBN with_IN caution_NN ,_, however_RB ,_, since_IN the_DT conventional_JJ definition_NN of_IN arousal_NN used_VBN may_MD not_RB accurately_RB reflect_VB aspects_NNS of_IN arousal_NN most_JJS relevant_JJ to_TO metabolic_JJ function_NN ._SENT Moreover_RB ,_, the_DT known_VBN lack_NN of_IN reliability_NN (_( 52_CD )_) in_IN measurement_NN of_IN cortical_JJ arousal_NN makes_VBZ arousal_NN frequency_NN a_DT weaker_JJR correlate_NN of_IN sleep-disordered_JJ breathing_NN severity_NN than_IN measures_NNS of_IN hypoxemia_NN ._SENT There_EX are_VBP two_CD other_JJ pathways_NNS through_IN which_WDT sleep-disordered_JJ breathing_NN may_MD lead_VB to_TO metabolic_JJ dysfunction_NN ._SENT First_RB ,_, numerous_JJ studies_NNS have_VBP shown_VBN that_IN patients_NNS with_IN sleep-disordered_JJ breathing_NN exhibit_NN elevated_VBD levels_NNS of_IN sympathetic_JJ neural_JJ traffic_NN (_( 53-56_CD )_) ._SENT Sympathetic_JJ hyperactivity_NN can_MD influence_VB glucose_NN homeostasis_NN by_IN increasing_VBG glycogen_NN breakdown_NN and_CC gluconeogenesis_NN ._SENT Further_JJR predisposition_NN toward_IN metabolic_JJ dysfunction_NN may_MD also_RB occur_VB through_IN effects_NNS of_IN sleep-disordered_JJ breathing_NN on_IN the_DT hypothalamic-pituitary-adrenal_JJ axis_NN ._SENT Experimental_JJ partial_JJ or_CC total_JJ sleep_NN deprivation_NN has_VBZ been_VBN shown_VBN to_TO increase_VB levels_NNS of_IN plasma_NN cortisol_NN on_IN the_DT following_VBG evening_NN at_IN a_DT time_NN when_WRB the_DT circadian_JJ rhythm_NN of_IN the_DT hypothalamic-pituitary-adrenal_JJ axis_NN is_VBZ at_IN its_PP$ nadir_NN (_( 57_CD )_) ._SENT The_DT increase_NN in_IN evening_NN cortisol_NN can_MD markedly_RB elevate_VB serum_NN glucose_NN levels_NNS and_CC insulin_NN concentrations_NNS and_CC increase_NN insulin_NN secretion_NN (_( 58_CD )_) ._SENT Although_IN the_DT paradigm_NN of_IN sleep_NN disruption_NN in_IN sleep-disordered_JJ breathing_NN is_VBZ different_JJ from_IN that_IN of_IN sleep_NN loss_NN ,_, a_DT study_NN of_IN patients_NNS with_IN sleep-disordered_JJ breathing_NN has_VBZ shown_VBN an_DT increase_NN in_IN levels_NNS of_IN serum_NN cortisol_NN (_( 59_CD )_) ._SENT Several_JJ methodological_JJ limitations_NNS should_MD be_VB recognized_VBN in_IN interpreting_VBG these_DT results_NNS ._SENT First_RB ,_, the_DT assessment_NN of_IN parameters_NNS of_IN metabolic_JJ function_NN ,_, which_WDT were_VBD measured_VBN as_IN part_NN of_IN the_DT parent_NN study_NN protocols_NNS ,_, was_VBD not_RB in_IN close_JJ temporal_JJ proximity_NN to_TO the_DT overnight_JJ polysomnogram_NN ._SENT To_TO our_PP$ knowledge_NN ,_, no_DT field_NN studies_NNS have_VBP examined_VBN the_DT link_NN between_IN sleep-disordered_JJ breathing_NN and_CC metabolic_JJ dysfunction_NN in_IN a_DT large_JJ nonclinical_JJ sample_NN ._SENT Thus_RB ,_, the_DT current_JJ study_NN provides_VBZ unique_JJ information_NN on_IN the_DT potential_JJ impact_NN of_IN sleep-disordered_JJ breathing_NN on_IN the_DT risk_NN of_IN metabolic_JJ dysfunction_NN ._SENT As_IN expected_VBN ,_, sensitivity_NN analyses_NNS confirmed_VBD that_IN as_IN the_DT time_NN window_NN between_IN the_DT metabolic_JJ assessment_NN and_CC the_DT polysomnogram_NN decreased_VBD ,_, the_DT strength_NN of_IN the_DT associations_NNS increased_VBD ._SENT Second_RB ,_, although_IN we_PP avoided_VBD the_DT potential_NN for_IN confounding_VBG by_IN race_NN by_IN using_VBG a_DT sample_NN that_WDT was_VBD predominantly_RB White_NP ,_, the_DT generalizability_NN of_IN the_DT presented_VBN results_NNS to_TO other_JJ racial_JJ and_CC ethnic_JJ groups_NNS is_VBZ limited_VBN ._SENT Third_JJ ,_, the_DT study_NN sample_NN was_VBD based_VBN on_IN independently_RB recruited_VBN parent_NN cohorts_NNS ,_, and_CC the_DT possibility_NN of_IN confounding_VBG by_IN cohort_NN effects_NNS must_MD be_VB considered--including_VBG the_DT possibility_NN of_IN residual_JJ confounding_VBG due_JJ to_TO age_NN ,_, given_VBN the_DT heterogeneity_NN of_IN age_NN distributions_NNS across_IN parent_NN cohorts_NNS ._SENT Finally_RB ,_, assessment_NN of_IN glucose_NN tolerance_NN and_CC insulin_NN resistance_NN was_VBD based_VBN on_IN measures_NNS of_IN fasting_VBG serum_NN glucose_NN or_CC insulin_NN level_NN and_CC oral_JJ glucose_NN tolerance_NN testing_NN ,_, instead_RB of_IN more_JJR sensitive_JJ measures_NNS such_JJ as_IN the_DT intravenous_JJ glucose_NN tolerance_NN test_NN or_CC the_DT euglycemic_JJ insulin_NN clamp_NN method_NN (_( 60_CD )_) ._SENT However_RB ,_, the_DT participant_NN burden_NN associated_VBN with_IN more_JJR sensitive_JJ measures_NNS precludes_VBZ their_PP$ use_NN in_IN large-scale_JJ epidemiologic_JJ studies_NNS ._SENT Despite_IN these_DT limitations_NNS ,_, the_DT results_NNS of_IN this_DT study_NN have_VBP significant_JJ implications_NNS given_VBN the_DT alarming_JJ trends_NNS in_IN obesity_NN ,_, a_DT well-established_JJ risk_NN factor_NN for_IN sleep-disordered_JJ breathing_NN ._SENT Although_IN obesity_NN can_MD have_VB detrimental_JJ effects_NNS on_IN metabolic_JJ function_NN ,_, the_DT results_NNS presented_VBD here_RB indicate_VB that_DT sleep-disordered_JJ breathing_NN may_MD also_RB impair_VB glucose_NN homeostasis_NN and_CC thus_RB explain_VB the_DT excess_JJ risk_NN of_IN hypertension_NN and_CC cardiovascular_JJ disease_NN associated_VBN with_IN sleep-disordered_JJ breathing_NN ._SENT Epidemiologic_JJ studies_NNS support_VBP the_DT notion_NN that_IN hyperglycemia_NN and_CC insulin_NN resistance_NN promote_VBP atherosclerosis_NN (_( 61_CD )_) and_CC increase_VB the_DT risk_NN of_IN myocardial_JJ infarction_NN (_( 14-16_CD )_) ,_, stroke_NN (_( 62_CD ,_, 63_CD )_) ,_, and_CC peripheral_JJ vascular_JJ disease_NN (_( 64_CD )_) ._SENT Previous_JJ work_NN (_( 65_CD )_) from_IN the_DT SHHS_NP has_VBZ shown_VBN that_IN subjects_NNS with_IN clinically_RB 